cnbc
JPMorgan says controversial eye disease treatment can more than double this biopharma stock
CNBC • 2 YEARS AGO
Streaming companies chase Spanish-language sports rights to capture growing Hispanic viewership
CNBC • 2 YEARS AGO
Inflation is 'always going to be a risk' with the U.S. economy now fundamentally changed, ADP chief economist says
CNBC • 2 YEARS AGO
Philips shares fall 7% after U.S. drug regulator deals fresh blow to sleep device recall
CNBC • 2 YEARS AGO
Bosses want people back in the office, but employees are finding a workaround—it's called 'coffee badging'
CNBC • 2 YEARS AGO
'Tremendous opportunity': Oakmark's Bill Nygren says it's a good time to buy these 3 cheap stocks
CNBC • 2 YEARS AGO